The Biden administration has put the finishing touches on the steps entities covered under the 340B Drug Discount Program must take to resolve disputes with drug manufacturers. The final rule, issued ...
Providers and drugmakers are once again at odds over the 340B drug discount program: this time, over a rule finalized by the Biden administration on Thursday making changes to its dispute resolution ...
The American Hospital Association is urging CMS to adjust its newly established drug price negotiation program, arguing the agency’s current approach conflicts with 340B programs. In a May 1 open ...
The Trump administration is pushing significant changes to the healthcare status quo that it says will save money, improve oversight and make the $4.9 trillion sector more efficient. Many of the HHS’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback